Clovis Oncology Inc. buy Traumtanz
Start price
29.01.21
/
70%
€6.91
Target price
€8.00
Performance (%)
16.27%
End price
06.02.21
€8.03
Summary
This prediction ended on 06.02.21 with a price of €8.03. The BUY prediction by Traumtanz finished with a performance of 16.27%. Traumtanz has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clovis Oncology Inc. | - | - | - | - |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% | 60.422% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% | 87.823% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% | 66.929% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% | 60.457% |
According to Traumtanz what are the pros and cons of Clovis Oncology Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Traumtanz for this prediction
In the thread Clovis Oncology Inc. diskutieren
